Analysis of human plasma products: Polymerase chain reaction does not discriminate between live and inactivated viruses

Transfusion

Volumn 37, Issue 9, 1997, Pages 935-940

  Hilfenhaus, J ^a,b   Groner A ^a   Nowak, T ^a,b   Weimer, T ^a,b  

^a Research Laboratories   (Germany)

^b Boehringer Mannheim   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD DONOR; BOVINE DIARRHEA VIRUS; CHIMPANZEE; CONTROLLED STUDY; HEAT TREATMENT; HEP 2 CELL; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PASTEURIZATION; PLASMA; POLIOMYELITIS VIRUS; POLYMERASE CHAIN REACTION; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS TITRATION;

EID: 1842417124     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37997454021.x     Document Type: Article

References (19)

1. WHO Expert Committee on Biological Standardization. Requirements for the collection, processing, and quality control of blood, blood components, and plasma derivatives. 39th Report. Technical Report Series 1989;786:159-60.
2. EEC regulatory document. Note for guidance. Validation of virus removal and inactivation procedures. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines. Biologicals 1991;19:247-51.
3. Mannucci PM. Viral safety of coagulation factor concentrates. Dev Biol Stand 1993;81:253-9.
4. Willkommen H, Löwer J. Theoretical considerations on viral inactivation or elimination. Dev Biol Stand 1993;81:109-16.
5. Anderle K. Die IQ-PCR und die Virussicherheit von Plasmapräparaten. Gesund Forschung 1995;7(1):11-3.
6. Wengler G, Bradley DW, Collett MS, et al. Flaviviridae. In: Murphy FA, et al., eds. Virus taxonomy: classification and nomenclature of viruses. New York: Springer-Verlag, 1995:415-27.
7. Bernhardt D. Rinderovarzelle (FROv) zur Virusvermehrung. European Patent Office 1994: No. EP 0 616 031 A2.
8. Finney DJ. Statistical method in biological assay. 3rd ed. London: Charles Griffin & Co., 1978:394-8.
9. Ishizawa M, Kobayashi Y, Miyamura T, Matsuura S. Simple procedure of DNA isolation from human serum. Nucleic Acids Res 1991;19:5792.
10. Yun ZB, Lindh G, Weiland O, et al. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors. J Med Virol 1993;39:57-61.
11. Qi F, Ridpath JF, Lewis T, et al. Analysis of the bovine viral diarrhea virus genome for possible cellular insertions. Virology 1992;189:285-92.
12. Bukh J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci U S A 1992;89:187-91.
13. Feinstone SM, Alter HJ, Dienes HP, Purcell RH. Studies on non-A, non-B hepatitis in chimpanzees and marmosets. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral hepatitis: international symposium. Philadelphia: Franklin Institute Press, 1982:295-304.
14. Quint WG, Heijtink RA, Schirm J, et al. Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol 1995;33:225-8.
15. Horowitz B, Wiebe ME, Lippin A, Stryker MH. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations. Transfusion 1985;25:516-22.
16. Nowak T, Klockman U, Hilfenhaus J. Inactivation of viruses related to hepatitis C virus by pasteurization in human plasma derivatives. Biologicals 1992;20:83-5.
17. Hart H, McOmish F, Hart WG, et al. A comparison of polymerase chain reaction and an infectivity assay for human immunodeficiency virus type 1 titration during virus inactivation of blood components. Transfusion 1993;33:838-41.
18. Hart HF, Hart WG, Crossley J, et al. Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates. Vox Sang 1994;67:345-50.
19. Hogle JM, Chow M, Filman DJ. Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 1985;229:1358-65.